benserazide has been researched along with neurotensin in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bobkova, NV; Bondarenko, NA; Gudasheva, TA; Ostrovskaya, RU; Retyunskaya, MV; Samokhin, AN | 1 |
Bourhis, E; Lévesque, D; Rouillard, C; St-Hilaire, M | 1 |
2 other study(ies) available for benserazide and neurotensin
Article | Year |
---|---|
Cholinopositive effect of dilept (neurotensin peptidomimetic) as the basis of its mnemotropic effect.
Topics: Alzheimer Disease; Animals; Avoidance Learning; Benserazide; Drug Combinations; Levodopa; Male; Memory; Mice; Mice, Inbred Strains; Muscarinic Antagonists; Neurotensin; Olfactory Bulb; Peptides; Rats; Rats, Wistar; Receptors, Muscarinic; Schizophrenia; Scopolamine; Space Perception | 2005 |
Impaired behavioural and molecular adaptations to dopamine denervation and repeated L-DOPA treatment in Nur77-knockout mice.
Topics: Adaptation, Physiological; Animals; Antiparkinson Agents; Benserazide; Corpus Striatum; Denervation; Disease Models, Animal; DNA-Binding Proteins; Dopamine; Dopamine Agents; Drug Resistance; Enkephalins; Levodopa; Mice; Mice, Inbred C57BL; Mice, Knockout; Motor Activity; Neural Pathways; Neurotensin; Nuclear Receptor Subfamily 4, Group A, Member 1; Parkinson Disease; Receptors, Cytoplasmic and Nuclear; Receptors, Dopamine D3; Receptors, Steroid; Transcription Factors | 2006 |